Chamber Finds Drug Price Measures Will Stifle Research
The U.S. Chamber of Commerce on Monday released a study examining clinical trial data that indicated the Biden administration's proposal to seize drug patents if the price is deemed unreasonable would...To view the full article, register now.
Already a subscriber? Click here to view full article